We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
A professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol
A study was performed among the type 2 diabetes patients attending M.V. Hospital for Diabetes in Chennai
Hypertension and diabetes are major risk factors for cardiovascular disease (CVD)
Millions at risk from 'silent killer' as NHS campaign warns there are often 'no clues' when it comes to high blood pressure.
A resource to help commissioners provide cost-effective interventions to prevent cardiovascular disease.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Evidence and guidance to help healthcare professionals to prevent heart attacks, strokes and dementia and to improve cardiovascular health.
Current cardiovascular disease (CVD) prevention is based on diagnosis and treatment of specific disease
This policy brief shares findings from a pragmatic, cluster randomised controlled trial in Zhejiang province, China
Cardiovascular disease (CVD) is a major cause of death in China
This article assesses practices in a rural ‘township hospital’ and compares them with international evidence-based practice
This publication brings together Public Health England's (PHE’s) broad-ranging work in addressing cardiovascular disease.
Update of cardiovascular disease (CVD) profile indicators for heart disease, diabetes, kidney disease and stroke data for commissioning organisations.
This report examines the current evidence about cardiovascular disease in the North East of England.
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).